PL3067353T3 - Sposób wytwarzania soli solifenacyny i ich włączenie do farmaceutycznych postaci dawkowania - Google Patents
Sposób wytwarzania soli solifenacyny i ich włączenie do farmaceutycznych postaci dawkowaniaInfo
- Publication number
- PL3067353T3 PL3067353T3 PL16156678T PL16156678T PL3067353T3 PL 3067353 T3 PL3067353 T3 PL 3067353T3 PL 16156678 T PL16156678 T PL 16156678T PL 16156678 T PL16156678 T PL 16156678T PL 3067353 T3 PL3067353 T3 PL 3067353T3
- Authority
- PL
- Poland
- Prior art keywords
- inclusion
- preparation
- dosage forms
- pharmaceutical dosage
- solifenacin
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title 1
- FBOUYBDGKBSUES-VXKWHMMOSA-N solifenacin Chemical class C1([C@H]2C3=CC=CC=C3CCN2C(O[C@@H]2C3CCN(CC3)C2)=O)=CC=CC=C1 FBOUYBDGKBSUES-VXKWHMMOSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200800188 | 2008-07-29 | ||
| SI200800285 | 2008-11-20 | ||
| SI200900113 | 2009-04-21 | ||
| EP09777523A EP2310387A2 (en) | 2008-07-29 | 2009-07-29 | A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms |
| EP16156678.1A EP3067353B1 (en) | 2008-07-29 | 2009-07-29 | A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3067353T3 true PL3067353T3 (pl) | 2018-04-30 |
Family
ID=41610777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16156678T PL3067353T3 (pl) | 2008-07-29 | 2009-07-29 | Sposób wytwarzania soli solifenacyny i ich włączenie do farmaceutycznych postaci dawkowania |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP3067353B1 (pl) |
| HR (1) | HRP20180150T1 (pl) |
| PL (1) | PL3067353T3 (pl) |
| SI (1) | SI3067353T1 (pl) |
| WO (1) | WO2010012459A2 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE030376T2 (en) * | 2009-02-27 | 2017-05-29 | Krka D D Novo Mesto | A method of preparing a solid oral dosage form comprising solifenacin and its pharmaceutically acceptable salts |
| JP4816828B2 (ja) * | 2009-03-30 | 2011-11-16 | アステラス製薬株式会社 | ソリフェナシン非晶質体を含有した固形医薬組成物 |
| US8765785B2 (en) | 2010-07-05 | 2014-07-01 | Crystal Pharma, S.A.U. | Solifenacin salts |
| EP2638039A1 (de) * | 2010-11-11 | 2013-09-18 | Hexal AG | Kristallines solifenacin-succinat |
| EP2500013B1 (en) * | 2011-03-15 | 2019-10-02 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pharmaceutical composition comprising solifenacin |
| EP2778167A1 (en) * | 2013-03-11 | 2014-09-17 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Stable pharmaceutical composition comprising amorphous solifenacin or its pharmaceutically acceptable salt |
| JP2015189677A (ja) * | 2014-03-27 | 2015-11-02 | テバ製薬株式会社 | ソリフェナシン非晶質体を含有する医薬組成物 |
| CN112552237B (zh) * | 2020-12-23 | 2022-10-14 | 中山奕安泰医药科技有限公司 | 索菲那新中间体的精制方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2005012I1 (no) | 1994-12-28 | 2005-06-06 | Debio Rech Pharma Sa | Triptorelin og farmasoytisk akseptable salter derav |
| JP3701964B1 (ja) | 2005-03-08 | 2005-10-05 | アステラス製薬株式会社 | キヌクリジン誘導体の新規な塩 |
| WO2007076116A2 (en) | 2005-12-21 | 2007-07-05 | Teva Pharmaceutical Industries Ltd. | Intermediates for preparing solifenacin |
| EP2046751A4 (en) | 2006-07-19 | 2010-12-29 | Reddys Lab Ltd Dr | PROCESS FOR PRODUCING SOLIFENACIN AND ITS SALTS |
| EP1943248A2 (en) | 2006-08-03 | 2008-07-16 | Teva Pharmaceutical Industries Ltd. | Solifenacin base forms and preparation thereof |
| CZ300692B6 (cs) | 2006-12-22 | 2009-07-15 | Zentiva, A. S. | Zpusob prípravy solifenacinu |
| EP2229387A1 (en) * | 2007-12-04 | 2010-09-22 | Cadila Healthcare Limited | Process for preparing chemically and chirally pure solifenacin base and its salts |
-
2009
- 2009-07-29 WO PCT/EP2009/005497 patent/WO2010012459A2/en not_active Ceased
- 2009-07-29 EP EP16156678.1A patent/EP3067353B1/en active Active
- 2009-07-29 PL PL16156678T patent/PL3067353T3/pl unknown
- 2009-07-29 EP EP09777523A patent/EP2310387A2/en not_active Withdrawn
- 2009-07-29 SI SI200931781T patent/SI3067353T1/en unknown
-
2018
- 2018-01-26 HR HRP20180150TT patent/HRP20180150T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20180150T1 (hr) | 2018-03-09 |
| WO2010012459A3 (en) | 2010-08-05 |
| SI3067353T1 (en) | 2018-03-30 |
| EP3067353B1 (en) | 2017-11-22 |
| WO2010012459A2 (en) | 2010-02-04 |
| EP2310387A2 (en) | 2011-04-20 |
| EP3067353A1 (en) | 2016-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL206500A0 (en) | Process for the preparation of sitagliptin and pharmaceutically acceptable salts thereof | |
| ZA201006029B (en) | Pharmaceutical dosage form | |
| EP2429506A4 (en) | DOSAGE FOR COATED PHARMACEUTICAL CAPSULES | |
| IL219120A (en) | Cyclohaphtha pyridinyl derivatives and their use in drug preparation | |
| ZA200906899B (en) | Process for preparation of erlotinib and its pharmaceutically acceptable salts | |
| ZA201304709B (en) | A pharmaceutical dosage form | |
| IL206159A0 (en) | Oral pharmaceutical dosage forms | |
| SI2400954T1 (sl) | Postopek za pripravo trdne oralne dozirne oblike solifenacina in njegovih farmacevtsko sprejemljivih soli | |
| HUP1000069A2 (en) | New salts for the preparation of pharmaceutical composition | |
| PL2588090T3 (pl) | Doustne farmaceutyczne postacie dawkowania zawierające eteksylan dabigatranu i jego farmaceutycznie dopuszczalne sole | |
| EP2086945A4 (en) | NOVEL PROCESS FOR THE PRODUCTION OF STATINES AND THEIR PHARMACEUTICAL ACCEPTIC SALTS | |
| PL3067353T3 (pl) | Sposób wytwarzania soli solifenacyny i ich włączenie do farmaceutycznych postaci dawkowania | |
| IL213502A (en) | Use of agonist d1 / d2 compounds for drug preparation | |
| TWI559929B (en) | Pharmaceutical composition for use in the treatment of a neurodegenerative disease | |
| ZA200903858B (en) | Pharmaceutical dosage form | |
| SI2394648T1 (sl) | Farmacevtski sestavek za oralno dajanje | |
| IL219617A0 (en) | Pharmaceutical solid dosage form | |
| SI2736909T1 (sl) | Proces za pripravo sitagliptina in njegovih farmacevtsko sprejemljivih soli | |
| SI2536396T1 (sl) | Postopek za pripravo oralnih trdnih odmernih oblik, ki obsegajo valsartan | |
| PL2291374T3 (pl) | Sposób wytwarzania solifenacyny i/lub jej farmaceutycznie dopuszczalnych soli o wysokiej czystości farmaceutycznej | |
| HU1000299D0 (en) | Nanostructured atorvastatin, its pharmaceutically acceptable salts and pharmaceutical compositions containing them and process for their preparation | |
| WO2011018801A3 (en) | Solid oral dosage form of ziprasidone | |
| HU1000444D0 (en) | Process for the preparation of a pharmaceutical active ingredient | |
| PL2714042T3 (pl) | Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego | |
| HU0900482D0 (en) | Pharmaceutical formulation for oral administration |